CS028

Solid Tumor

Pre‑clinicalActive

Key Facts

Indication

Solid Tumor

Phase

Pre‑clinical

Status

Active

Company

Taiwan biotech advancing breakthrough stroke and pain therapies with a strong licensing and co‑development model.

Drug	Company	Phase	Status
AV-203	AVEO Oncology	Pre-clinical	Active
LR19155	AVEO Oncology	Pre-clinical	Active
LR20011	AVEO Oncology	Pre-clinical	Active
LR19129	AVEO Oncology	Pre-clinical	Active
LR19023	AVEO Oncology	Pre-clinical	Active
Undisclosed Transcription Factor	Talus Bioscience	Discovery	Active
RGI-AB-01	REGiMMUNE	Preclinical	Active
RGI-AB-02	REGiMMUNE	Preclinical	Active
RGI-AB-03	REGiMMUNE	Preclinical	Active
RGI-AB-04	REGiMMUNE	Preclinical	Active